Orgenesis Inc. | Mutual Funds

Mutual Funds that own Orgenesis Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Extended Market Index Fund
143,392
0.96%
0
0%
07/31/2018
iShares Micro Cap ETF
18,686
0.13%
0
0.01%
09/06/2018
3,615
0.02%
0
1%
05/31/2018
Vanguard Total Stock Market Index Trust
1,425
0.01%
0
0%
07/31/2018

About Orgenesis

View Profile
Address
20271 Goldenrod Lane
Germantown Maryland 20876
United States
Employees -
Website http://www.orgenesis.com
Updated 07/08/2019
Orgenesis, Inc. engages in the cell therapy development and manufacturing for advanced medicinal products. It focuses on developing novel and proprietary cell therapy trans-differentiation technologies for the treatment of diabetes. It operates through the Contract Development and Manufacturing Organization (CDMO), and Cellular Therapy Business (CT) segments.